Latest News about Jazz
Recent news which mentions Jazz
EXCLUSIVE: Cannabis-Based Drug Approved For Cancer Treatment In Peru
November 22, 2021
Tickers
JAZZ
From Benzinga
2 Top Marijuana Stocks to Buy for the Long Haul
November 21, 2021
From Motley Fool
Better Buy: Compass Pathways vs. Jazz Pharmaceuticals
November 21, 2021
From Motley Fool
Is Now the Right Time to Buy Compass Pathways?
November 13, 2021
From Motley Fool
The Week In Cannabis: Earnings Season, A GOP Legalization Bill, Seth Rogen & Sarah Silverman's Campaign
November 12, 2021
From Benzinga
Is Compass Pathways Stock a Once-in-a-Lifetime Bargain?
November 11, 2021
From Motley Fool
7 F-Rated Stocks to Sell Before We Reach Christmas
November 10, 2021
From InvestorPlace
Jazz Pharmaceuticals PLC (JAZZ) Q3 2021 Earnings Call Transcript
November 10, 2021
Tickers
JAZZ
From Motley Fool
Jazz Pharmaceuticals Reports Q3 Financial Results, Raises Full-Year Earnings Guidance
November 09, 2021
Tickers
JAZZ
From Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
From Benzinga
Lexaria Announces DehydraTECH-CBD Versus Prescription CBD Program In Treating Seizures
November 01, 2021
From Benzinga
2 Top Growth Stocks to Buy Heading Into November
October 30, 2021
From Motley Fool
7 Top Stocks to Buy On Any Dip If You Get the Chance in Q4
October 27, 2021
Tags
JPM
NYSE:JPM,OTCMKTS:EGRNY,NASDAQ:DLTR,NYSE:IBM,NASDAQ:JAZZ,NYSE:OHI,NYSE:PSFE,NYSE:VALE,NASDAQ:ZNGA
IBM
From InvestorPlace
From Benzinga
Bob Holz to release new album featuring John Mclaughlin, Jean Luc Ponty, Darryl Jones and Randy Brecker
October 26, 2021
Tickers
JAZZ
From PRLog
3 Dirt-Cheap Stocks Wall Street Thinks Will Soar 43% to 80%
October 22, 2021
From Motley Fool
Leading the Charge to Develop the First Orexin-Targeted Therapy to Address Narcolepsy at its Root Cause
October 20, 2021
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2021
October 05, 2021
From Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
From Benzinga
From Benzinga
Needham Initiates Coverage With Buy For This Narcolepsy Player
September 23, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021
September 23, 2021
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
September 22, 2021
From Benzinga
September Sell-Off: 3 Dirt Cheap Growth Stocks to Buy
September 22, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
